Primary Aldosteronism

Слайд 2

Adrenal Steroids MK GK Andro KA

Adrenal Steroids

MK

GK

Andro

KA

Слайд 3

Renin-Angiotensin-Aldosterone System

Renin-Angiotensin-Aldosterone System

Слайд 4

Ion Transport in Collecting Tubule Principal Cells

Ion Transport in Collecting Tubule Principal Cells

Слайд 5

Nonsuppressible (primary) hypersecretion of aldosterone is an underdiagnosed cause of hypertension.


Nonsuppressible (primary) hypersecretion of aldosterone is an underdiagnosed cause of

hypertension.
1-2% in unselected patients with hypertension.
10-20% in patients with resistant hypertension.
1% of adrenal incidentaloma = aldosteronoma.
Слайд 6

Resistant hypertension - failure to achieve goal blood pressure (BP) despite

Resistant hypertension - failure to achieve goal blood pressure (BP) despite

adherence to an appropriate three-drug regimen including a diuretic.
Refractory hypertension – failure to control the BP even with maximal medical therapy (four or more drugs with complementary mechanisms given at maximal tolerated doses) under the care of a hypertension specialist.
Слайд 7

Слайд 8

Clinical Features of Primary Aldosteronism Hypertension Hypokalemia only 40-50% Lack of

Clinical Features of Primary Aldosteronism

Hypertension
Hypokalemia only 40-50%
Lack of edema
Metabolic alkalosis
Mild hypernatremia,

hypomagnesemia
↑ GFR, polyuria, proteinuria, CRF
Muscle weakness&cramps (hypokalemia less than 2.5 meq/L)
LVH, MI, CVA, AF
Слайд 9

Subtypes of Primary Aldosteronism Adenoma Hyperplasia

Subtypes of Primary Aldosteronism

Adenoma

Hyperplasia

Слайд 10

Слайд 11

Screening for Primary Aldosteronism severe hypertension (>160/100 mmHg) or drug-resistant hypertension

Screening for Primary Aldosteronism

severe hypertension (>160/100 mmHg) or drug-resistant hypertension
HTN

and spontaneous or diuretic-induced hypokalemia
hypertension with adrenal incidentaloma
hypertension and a family history of early onset hypertension or CVA at a young age (<40 years)
case detection for all hypertensive first-degree relatives of patients with PA is recommend
Слайд 12

Screening (cont.) Plasma Aldosterone-to-Renin ratio mid-morning, after the patient has been

Screening (cont.)

Plasma Aldosterone-to-Renin ratio
mid-morning, after the patient has been up for

at least 2 hours and seated for 5-15 minutes
have to be withdrawn for at least 4 weeks:
Spironolactone, eplerenone, amiloride, and triamterene
Potassium-wasting diuretics
Confectionary licorice, chewing tobacco
Results:
PRA↓
PAC ≥15 ng/dL (416 pmol/L)
PAC/PRA ≥20
Слайд 13

Confirmation of the Diagnosis Oral sodium loading 24-h urine Na excretion

Confirmation of the Diagnosis

Oral sodium loading
24-h urine Na excretion >200

meq
Urine Aldo excretion>12 mkg/24h
Saline infusion test
PAC>10 ng/dL (>277 pmol/L)
normal <5 ng/dL
Слайд 14

Слайд 15

Imaging CT scan MRI Adrenal venous sampling Iodocholesterol scintigraphy

Imaging

CT scan
MRI
Adrenal venous sampling
Iodocholesterol scintigraphy

Слайд 16

Adenoma vs. Bilateral Hyperplasia

Adenoma vs. Bilateral Hyperplasia

Слайд 17

Diagnosis of Primary Aldosteronism Lab. Tests Adrenal CT Scan Unilateral Hypodense

Diagnosis of Primary Aldosteronism

Lab. Tests

Adrenal CT Scan

Unilateral Hypodense Nodule 1-2 sm

Normal,
Micronodular,
Bilateral

Masses,
Atypical Mass (>2 sm)

Older than 40 y

Younger than 40 y

Lap. Adrenalectomy

Surgery Desired

Surgery Not Desired

AVS

Pharmacologic Therapy

Слайд 18

Adrenal Venous Sampling

Adrenal Venous Sampling

Слайд 19

Treatment HTN is improved in all and is cured in 35-60% of pt.

Treatment

HTN is improved in all and is cured in 35-60% of

pt.